229
Views
10
CrossRef citations to date
0
Altmetric
Original Research

The Relevance of Small Airway Dysfunction in Asthma with Nocturnal Symptoms

ORCID Icon, ORCID Icon, , , , , , , , , , & show all
Pages 897-905 | Published online: 13 Jul 2021

References

  • Lemanske RF, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol. 2010;125(2):S95–S102. doi:10.1016/j.jaci.2009.10.047
  • Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med. 1988;85(1B):6–8. doi:10.1016/0002-9343(88)90231-8
  • Raherison C, Abouelfath A, Le Gros V, Taytard A, Molimard M. Underdiagnosis of nocturnal symptoms in asthma in general practice. J Asthma. 2006;43(3):199–202. doi:10.1080/02770900600566744
  • Greenberg H, Cohen RI. Nocturnal asthma. Curr Opin Pulm Med. 2012;18(1):57–62. doi:10.1097/MCP.0b013e32834d098e
  • Calhoun WJ. Nocturnal asthma. Chest. 2003;123(3 Suppl):399S–405S. doi:10.1378/chest.123.3_suppl.399S
  • Sutherland ER. Nocturnal asthma. J Allergy Clin Immunol. 2005;116(6):1179–86; quiz 1187. doi:10.1016/j.jaci.2005.09.028
  • Kraft M, Pak J, Martin RJ, Kaminsky D, Irvin CG. Distal lung dysfunction at night in nocturnal asthma. Am J Respir Crit Care Med. 2001;163(7):1551–1556. doi:10.1164/ajrccm.163.7.2008013
  • Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med. 1996;154(5):1505–1510. doi:10.1164/ajrccm.154.5.8912772
  • Postma DS, Brightling C, Baldi S, et al. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study. Lancet Respir Med. 2019;7(5):402–416. doi:10.1016/S2213-2600(19)30049-9
  • Abdo M, Trinkmann F, Kirsten A-M, et al. Small Airway Dysfunction Links Asthma Severity with Physical Activity and Symptom Control. J Allergy Clin Immunol Pract. 2021. doi:10.1016/j.jaip.2021.04.035
  • Fuchs O, Bahmer T, Weckmann M, et al. The all age asthma cohort (ALLIANCE) - from early beginnings to chronic disease: a longitudinal cohort study. BMC Pulm Med. 2018;18(1):140. doi:10.1186/s12890-018-0705-6
  • Schatz M, Sorkness CA, Li JT, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549–556. doi:10.1016/j.jaci.2006.01.011
  • Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest. 1999;115(5):1265–1270. doi:10.1378/chest.115.5.1265
  • Smets EM, Garssen B, Bonke B, Haes JCD. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–325. doi:10.1016/0022-3999(94)00125-O
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511–522. doi:10.1183/09031936.05.00035005
  • Oostveen E, MacLeod D, Lorino H, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22(6):1026–1041. doi:10.1183/09031936.03.00089403
  • Robinson PD, Latzin P, Verbanck S, et al. Consensus statement for inert gas washout measurement using multiple- and single- breath tests. Eur Respir J. 2013;41(3):507–522. doi:10.1183/09031936.00069712
  • Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(Suppl 16):5–40. doi:10.1183/09041950.005s1693
  • Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312
  • Pedersen F, Zissler UM, Watz H, Rabe KF, Hohlfeld JM, Holz O. Rating sputum cell quality in clinical trials for asthma and COPD treatment. Int J Chron Obstruct Pulmon Dis. 2019;14:195–198. doi:10.2147/COPD.S188033
  • Paggiaro PL, Chanez P, Holz O, et al. Sputum induction. Eur Respir J Suppl. 2002;37:3s–8s. doi:10.1183/09031936.02.00000302
  • Dweik RA, Boggs PB, Erzurum SC, et al. An Official ATS Clinical Practice Guideline: interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications. Am J Respir Crit Care Med. 2011;184(5):602–615. doi:10.1164/rccm.9120-11ST
  • Sundar IK, Yao H, Sellix MT, Rahman I. Circadian molecular clock in lung pathophysiology. Am J Physiol Lung Cell Mol Physiol. 2015;309(10):L1056–75. doi:10.1152/ajplung.00152.2015
  • Rabe KF, Jörres R, Nowak D, Behr N, Magnussen H. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Am Rev Respir Dis. 1993;147(6 Pt 1):1436–1441. doi:10.1164/ajrccm/147.6_Pt_1.1436
  • Hetzel MR, Clark TJ. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax. 1980;35(10):732–738. doi:10.1136/thx.35.10.732
  • Martin RJ, Cicutto LC, Ballard RD. Factors related to the nocturnal worsening of asthma. Am Rev Respir Dis. 1990;141(1):33–38. doi:10.1164/ajrccm/141.1.33
  • Calhoun WJ, Bates ME, Schrader L, Sedgwick JB, Busse WW. Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. Am Rev Respir Dis. 1992;145(3):577–581. doi:10.1164/ajrccm/145.3.577
  • Mackay TW, Wallace WA, Howie SE, et al. Role of inflammation in nocturnal asthma. Thorax. 1994;49(3):257–262. doi:10.1136/thx.49.3.257
  • Postma DS, Oosterhoff Y, van Aalderen WM, Kauffman HF, Wempe JB, Koëter GH. Inflammation in nocturnal asthma? Am J Respir Crit Care Med. 1994;150(5 Pt 2):S83–6. doi:10.1164/ajrccm/150.5_Pt_2.S83
  • Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms. Eur Respir J. 2002;20(4):841–845. doi:10.1183/09031936.02.00202002
  • Hamid Q, Song Y, Kotsimbos TC, et al. Inflammation of small airways in asthma. J Allergy Clin Immunol. 1997;100(1):44–51. doi:10.1016/S0091-6749(97)70193-3
  • Synek M, Beasley R, Frew AJ, et al. Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med. 1996;154(1):224–230. doi:10.1164/ajrccm.154.1.8680684
  • Barnes N, Price D, Colice G, et al. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study. Clin Exp Allergy. 2011;41(11):1521–1532. doi:10.1111/j.1365-2222.2011.03820.x
  • van der Molen T, Postma DS, Martin RJ, et al. Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands. BMC Pulm Med. 2016;16(1):80. doi:10.1186/s12890-016-0234-0
  • Abdo M, Watz H, Veith V, et al. Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study. Respir Res. 2020;21(1):278. doi:10.1186/s12931-020-01543-5